Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning.
The report details the trend, potential and market size of Attention Deficit Hyperactivity Disorder market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Attention Deficit Hyperactivity Disordermarket, defines the market attractiveness level of Attention Deficit Hyperactivity Disorder market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Attention Deficit Hyperactivity Disorder industry, describes the types of Attention Deficit Hyperactivity Disorder market, the applications of major players and the market size, and deeply analyzes the current situation of the global Attention Deficit Hyperactivity Disorder market and the development prospects and opportunities of Attention Deficit Hyperactivity Disorder industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Attention Deficit Hyperactivity Disorder market in Chapter 13.
By Player:
Shire
Impax
Mallinckrodt
Novartis
Hisamitsu
Johnson & Johnson
UCB
Eli Lilly
Purdue Parma
GlaxoSmithKline
Pfizer
By Type:
Stimulants Drugs
Non-stimulants Drugs
By End-User:
Pediatric
Adolescent
Adults
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Attention Deficit Hyperactivity Disorder Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Attention Deficit Hyperactivity Disorder Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Attention Deficit Hyperactivity Disorder Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Attention Deficit Hyperactivity Disorder Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Attention Deficit Hyperactivity Disorder Market Analysis and Outlook to 2022
-
7.1 Global Attention Deficit Hyperactivity Disorder Consumption (2017-2022)
-
7.2 United States Attention Deficit Hyperactivity Disorder Consumption (2017-2022)
-
7.3 Europe Attention Deficit Hyperactivity Disorder Consumption (2017-2022)
-
7.4 China Attention Deficit Hyperactivity Disorder Consumption (2017-2022)
-
7.5 Japan Attention Deficit Hyperactivity Disorder Consumption (2017-2022)
-
7.6 India Attention Deficit Hyperactivity Disorder Consumption (2017-2022)
-
7.7 South Korea Attention Deficit Hyperactivity Disorder Consumption (2017-2022)
8 Region and Country-wise Attention Deficit Hyperactivity Disorder Market Analysis and Outlook to 2028
-
8.1 Global Attention Deficit Hyperactivity Disorder Consumption Forecast (2022-2028)
-
8.2 United States Attention Deficit Hyperactivity Disorder Consumption Forecast (2022-2028)
-
8.3 Europe Attention Deficit Hyperactivity Disorder Consumption Forecast (2022-2028)
-
8.4 China Attention Deficit Hyperactivity Disorder Consumption Forecast (2022-2028)
-
8.5 Japan Attention Deficit Hyperactivity Disorder Consumption Forecast (2022-2028)
-
8.6 India Attention Deficit Hyperactivity Disorder Consumption Forecast (2022-2028)
-
8.7 South Korea Attention Deficit Hyperactivity Disorder Consumption Forecast (2022-2028)
9 Global Attention Deficit Hyperactivity Disorder Market Outlook by Types and Applications to 2022
-
9.1 Global Attention Deficit Hyperactivity Disorder Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Stimulants Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-stimulants Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Attention Deficit Hyperactivity Disorder Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pediatric Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adolescent Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Adults Consumption and Growth Rate (2017-2022)
10 Global Attention Deficit Hyperactivity Disorder Market Outlook by Types and Applications to 2028
-
10.1 Global Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Stimulants Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-stimulants Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adolescent Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Adults Consumption Forecast and Growth Rate (2022-2028)
11 Global Attention Deficit Hyperactivity Disorder Import and Export Analysis (Top 5 Countries)
-
11.1 Global Attention Deficit Hyperactivity Disorder Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Attention Deficit Hyperactivity Disorder Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Attention Deficit Hyperactivity Disorder Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Attention Deficit Hyperactivity Disorder Market Competitive Analysis
-
14.1 Shire
-
14.1.1 Shire Company Details
-
14.1.2 Shire Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Shire Attention Deficit Hyperactivity Disorder Product and Service
-
14.2 Impax
-
14.2.1 Impax Company Details
-
14.2.2 Impax Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Impax Attention Deficit Hyperactivity Disorder Product and Service
-
14.3 Mallinckrodt
-
14.3.1 Mallinckrodt Company Details
-
14.3.2 Mallinckrodt Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Attention Deficit Hyperactivity Disorder Product and Service
-
14.5 Hisamitsu
-
14.5.1 Hisamitsu Company Details
-
14.5.2 Hisamitsu Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Hisamitsu Attention Deficit Hyperactivity Disorder Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Product and Service
-
14.7 UCB
-
14.7.1 UCB Company Details
-
14.7.2 UCB Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 UCB Attention Deficit Hyperactivity Disorder Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Attention Deficit Hyperactivity Disorder Product and Service
-
14.9 Purdue Parma
-
14.9.1 Purdue Parma Company Details
-
14.9.2 Purdue Parma Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Purdue Parma Attention Deficit Hyperactivity Disorder Product and Service
-
14.10 GlaxoSmithKline
-
14.10.1 GlaxoSmithKline Company Details
-
14.10.2 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Product and Service
-
14.11 Pfizer
-
14.11.1 Pfizer Company Details
-
14.11.2 Pfizer Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Pfizer Attention Deficit Hyperactivity Disorder Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Attention Deficit Hyperactivity Disorder
-
Figure Attention Deficit Hyperactivity Disorder Picture
-
Table Global Attention Deficit Hyperactivity Disorder Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Attention Deficit Hyperactivity Disorder Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Attention Deficit Hyperactivity Disorder Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Attention Deficit Hyperactivity Disorder Consumption by Country (2017-2022)
-
Figure United States Attention Deficit Hyperactivity Disorder Consumption and Growth Rate (2017-2022)
-
Table Europe Attention Deficit Hyperactivity Disorder Consumption and Growth Rate (2017-2022)
-
Figure China Attention Deficit Hyperactivity Disorder Consumption and Growth Rate (2017-2022)
-
Figure Japan Attention Deficit Hyperactivity Disorder Consumption and Growth Rate (2017-2022)
-
Figure India Attention Deficit Hyperactivity Disorder Consumption and Growth Rate (2017-2022)
-
Figure South Korea Attention Deficit Hyperactivity Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Attention Deficit Hyperactivity Disorder Consumption Forecast by Country (2022-2028)
-
Figure United States Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Attention Deficit Hyperactivity Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stimulants Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Non-stimulants Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric Consumption and Growth Rate (2017-2022)
-
Figure Global Adolescent Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Stimulants Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-stimulants Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adolescent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Attention Deficit Hyperactivity Disorder Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Attention Deficit Hyperactivity Disorder Export by Region (Top 5 Countries) (2017-2028)
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Attention Deficit Hyperactivity Disorder Product and Service
-
Table Impax (Foundation Year, Company Profile and etc.)
-
Table Impax Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Impax Attention Deficit Hyperactivity Disorder Product and Service
-
Table Mallinckrodt (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Attention Deficit Hyperactivity Disorder Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Attention Deficit Hyperactivity Disorder Product and Service
-
Table Hisamitsu (Foundation Year, Company Profile and etc.)
-
Table Hisamitsu Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hisamitsu Attention Deficit Hyperactivity Disorder Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder Product and Service
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Attention Deficit Hyperactivity Disorder Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Attention Deficit Hyperactivity Disorder Product and Service
-
Table Purdue Parma (Foundation Year, Company Profile and etc.)
-
Table Purdue Parma Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Parma Attention Deficit Hyperactivity Disorder Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Attention Deficit Hyperactivity Disorder Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Attention Deficit Hyperactivity Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Attention Deficit Hyperactivity Disorder Product and Service
-
